Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial
Crossref DOI link: https://doi.org/10.1007/s00198-014-2944-6
Published Online: 2014-11-29
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Bone, H. G.
Dempster, D. W.
Eisman, J. A.
Greenspan, S. L.
McClung, M. R.
Nakamura, T.
Papapoulos, S.
Shih, W. J.
Rybak-Feiglin, A.
Santora, A. C.
Verbruggen, N.
Leung, A. T.
Lombardi, A.
License valid from 2014-11-29